Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis

Table 1

Classification of drugs for the treatment of MDR-TB.

Second-line drug group	Drug type	Specific drugs
Group A	Fluoroquinolones	Levofloxacin; Moxifloxacin; Gatifloxacin
Group B	Second-line injectable agents	Amikacin; Capreomycin; Kanamycin; Streptomycin
Group C	Other core second-line agents	Ethionamide/prothionamide; Cycloserine/terizidone; Linezolid; Clofazimine
Group D	Group D1	Pyrazinamide; Ethambutol; High-dose isoniazid
Group D	Group D2	Bedaquiline; Delamanid
Group D	Group D3	p-Aminosalicylic acid; Imipenem-cilastatin; Meropenem; Amoxicillin-clavulanate; Thioacetazone